Literature DB >> 21414382

Advances in metal-induced oxidative stress and human disease.

Klaudia Jomova1, Marian Valko.   

Abstract

Detailed studies in the past two decades have shown that redox active metals like iron (Fe), copper (Cu), chromium (Cr), cobalt (Co) and other metals undergo redox cycling reactions and possess the ability to produce reactive radicals such as superoxide anion radical and nitric oxide in biological systems. Disruption of metal ion homeostasis may lead to oxidative stress, a state where increased formation of reactive oxygen species (ROS) overwhelms body antioxidant protection and subsequently induces DNA damage, lipid peroxidation, protein modification and other effects, all symptomatic for numerous diseases, involving cancer, cardiovascular disease, diabetes, atherosclerosis, neurological disorders (Alzheimer's disease, Parkinson's disease), chronic inflammation and others. The underlying mechanism of action for all these metals involves formation of the superoxide radical, hydroxyl radical (mainly via Fenton reaction) and other ROS, finally producing mutagenic and carcinogenic malondialdehyde (MDA), 4-hydroxynonenal (HNE) and other exocyclic DNA adducts. On the other hand, the redox inactive metals, such as cadmium (Cd), arsenic (As) and lead (Pb) show their toxic effects via bonding to sulphydryl groups of proteins and depletion of glutathione. Interestingly, for arsenic an alternative mechanism of action based on the formation of hydrogen peroxide under physiological conditions has been proposed. A special position among metals is occupied by the redox inert metal zinc (Zn). Zn is an essential component of numerous proteins involved in the defense against oxidative stress. It has been shown, that depletion of Zn may enhance DNA damage via impairments of DNA repair mechanisms. In addition, Zn has an impact on the immune system and possesses neuroprotective properties. The mechanism of metal-induced formation of free radicals is tightly influenced by the action of cellular antioxidants. Many low-molecular weight antioxidants (ascorbic acid (vitamin C), alpha-tocopherol (vitamin E), glutathione (GSH), carotenoids, flavonoids, and other antioxidants) are capable of chelating metal ions reducing thus their catalytic activity to form ROS. A novel therapeutic approach to suppress oxidative stress is based on the development of dual function antioxidants comprising not only chelating, but also scavenging components. Parodoxically, two major antioxidant enzymes, superoxide dismutase (SOD) and catalase contain as an integral part of their active sites metal ions to battle against toxic effects of metal-induced free radicals. The aim of this review is to provide an overview of redox and non-redox metal-induced formation of free radicals and the role of oxidative stress in toxic action of metals.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414382     DOI: 10.1016/j.tox.2011.03.001

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  559 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

Review 2.  Toxicological effects of major environmental pollutants: an overview.

Authors:  Samina Wasi; Shams Tabrez; Masood Ahmad
Journal:  Environ Monit Assess       Date:  2012-07-06       Impact factor: 2.513

3.  Trace elements are associated with urinary 8-hydroxy-2'-deoxyguanosine level: a case study of college students in Guangzhou, China.

Authors:  Shaoyou Lu; Lu Ren; Jianzhang Fang; Jiajia Ji; Guihua Liu; Jianqing Zhang; Huimin Zhang; Ruorong Luo; Kai Lin; Ruifang Fan
Journal:  Environ Sci Pollut Res Int       Date:  2016-01-19       Impact factor: 4.223

4.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

5.  Plants genotoxicity as pollution bioindicator in Jordan using comet assay.

Authors:  Wesam Al Khateeb
Journal:  Physiol Mol Biol Plants       Date:  2017-12-13

6.  Occupational exposure to metals and risk of meningioma: a multinational case-control study.

Authors:  Siegal Sadetzki; Angela Chetrit; Michelle C Turner; Martie van Tongeren; Geza Benke; Jordi Figuerola; Sarah Fleming; Martine Hours; Laurel Kincl; Daniel Krewski; Dave McLean; Marie-Elise Parent; Lesley Richardson; Brigitte Schlehofer; Klaus Schlaefer; Maria Blettner; Joachim Schüz; Jack Siemiatycki; Elisabeth Cardis
Journal:  J Neurooncol       Date:  2016-09-23       Impact factor: 4.130

7.  Correlation between heavy metal exposure and GSTM1 polymorphism in Iranian multiple sclerosis patients.

Authors:  Mehdi Aliomrani; Mohammad A Sahraian; Hamid Shirkhanloo; Mohammad Sharifzadeh; Mohammad R Khoshayand; Mohammad H Ghahremani
Journal:  Neurol Sci       Date:  2017-04-21       Impact factor: 3.307

8.  Blood trace minerals concentrations and oxidative stress in patients with obstructive sleep apnea.

Authors:  P C Chen; C H Guo; C J Tseng; K C Wang; P J Liu
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

9.  Ginsenoside Rg1 protects human umbilical cord blood-derived stromal cells against tert-Butyl hydroperoxide-induced apoptosis through Akt-FoxO3a-Bim signaling pathway.

Authors:  Ying Liu; Long Yi; Lu Wang; Linbo Chen; Xiongbin Chen; Yaping Wang
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

10.  Metallothionein blocks oxidative DNA damage induced by acute inorganic arsenic exposure.

Authors:  Wei Qu; Michael P Waalkes
Journal:  Toxicol Appl Pharmacol       Date:  2014-12-05       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.